News from the Node

The Northeast Node is proud to announce its newest CTN study, CTN-0116: Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder (PharmICO).

On Thursday, August 26, 2021, the CTN-0116 Lead Team hosted an Informational Session for prospective sites to learn more about the study. You can view the recording of that session below.

In addition, Site Selection material were sent to the full CTN, including a Brief Study Overview, EHR Extraction Summary, and the Site Selection Survey itself. Surveys are due back to the Lead Team no later than Friday, October 1.

Slides from this presentation are available here:  CTN-0116_Site Information_2021-0826

The Northeast Node has 2 open positions for a new study based at the Dartmouth-Hitchcock Addiction Treatment Program in Lebanon, NH.

The study is a clinical trial examining the retention, duration, and discontinuation of medication treatment for opioid use disorder; it will inform the science around how long patients with OUD stay in treatment as well as how medication discontinuation occurs in real-world settings.

The study is hiring two Research Assistants (RA) to join our team here in New Hampshire. We are hoping to hire people with research experience, as this study is complex and includes an Investigational New Drug (IND) for use of the CAM2038 extended-release buprenorphine product. Employment for these two positions would occur through the College and not D-H, though shared access will be granted for D-H systems needed to conduct the study.

 The RA position link is:  https://searchjobs.dartmouth.edu/postings/58366

Please share this notice within your networks, and with friends and family.

Previous research has found that chest-based sensors can detect cocaine use but are obtrusive. This study aimed to develop a wrist-based sensor capable of detecting cocaine use but less obtrusive than its predecessor.

Findings indicate that it is possible to use wrist-based sensing devices to detect cocaine use.

The full article can be found here, and the abstract is below.

(more…)

The Northeast Node was awarded a new CTN study: Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder.

(more…)

Since 2011, October has been a time to highlight the vital role of substance use prevention in both individual and community health, to remember those who have lost their lives to substance use, to acknowledge those in recovery, as well as children, parents, family, and friends supporting them.

A description of this year’s proclamation can be found at the White House website.

There are resources available at the National Institute on Drug Abuse website, including Lessons from Prevention Research and some Easy-to-Read Drug Facts, and The National Child Traumatic Stress Network has compiled a list of resources for parents and caregivers of children affected by parental substance use.

Two recently published articles use large health datasets to examine the intersection of the COVID-19 pandemic and mental and substance use disorders.

Wang Q,  Xu R, Volkow ND (2020).  Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry (Impact factor: 40.59).First published: 07 October 2020. https://doi.org/10.1002/wps.2080

Wang Q, Kaelber D, Xu R, Volkow ND (2020). COVID-19 Risk and Outcomes in patients with substance use disorders: Analyses from electronic health records in the United States. Molecular Psychiatry (2020) DOI https://doi.org/10.1038/s41380-020-00880-7.

The Northeast Node is now hiring a Research Assistant for a new study investigating a prevention strategy for opioid use disorder in primary care settings. This position is based at two primary care practices in Manchester and Bedford, New Hampshire. Once COVID-19 restrictions in the State of NH are lifted, this position will be based directly in these two clinics.

The right candidate is someone who is passionate about health services and helping people with opioid use disorder. Prior research experience is a bonus but we are willing to train the right person.

For more information about this posting, or to apply, please visit https://searchjobs.dartmouth.edu/postings/54706

Dartmouth College is an equal opportunity/affirmative action employer with a strong commitment to diversity and inclusion. We prohibit discrimination on the basis of race, color, religion, sex, age, national origin, sexual orientation, gender identity or expression, disability, veteran status, marital status, or any other legally protected status. Applications by members of all underrepresented groups are encouraged.

The COVID-19 pandemic presents unique challenges for people with substance use disorders (SUDs) and people in recovery. To address the urgency of this rapidly evolving situation, The National Institute on Drug Abuse (NIDA) has compiled a list of COVID-19 resource pages from federal agencies.

Visit NIDA’s website for more information.

Full Article

Bonny Whalen, MD, Steve Chapman, MD, Alison Holmes, MD, MPH, Julia Frew, MD (MED ’05), and Daisy Goodman, DNP, MPH (TDI ’14), received the Academic Pediatric Association’s (APA) Health Care Delivery award for their work with mothers and newborns with opioid dependence. The Center for Addiction Recovery in Pregnancy and Parenting (CARRP) is a multidisciplinary network of experienced clinicians and researchers working together to support recovery from addiction for women who are pregnant and parenting, and to promote healthy growth and development in their children.

For more information